CDSCO Panel grants Pfizer's protocol amendment proposal for Tofacitinib Dr. Divya Colin25 Dec 2022 4:42 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Submit Revised CT Protocol of FDC Gabapentin,Lidocaine Gel: CDSCO panel tells Akums Drugs Dr. Divya Colin25 Dec 2022 4:23 PM ISTNew Delhi: Reviewing the justification and Phase III clinical trial protocol presented by the drug-maker Akums Drugs & Pharmaceuticals for the...
Sun Pharma gets CDSCO Panel nod to study Tildrakuzimab Dr. Divya Colin23 Dec 2022 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has given its nod to study the...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 3:31 PM ISTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
Dr Mansukh Mandaviya inaugurates new building of CDSCO Bhawan, South Zone in Chennai Ruchika Sharma23 Dec 2022 1:30 PM ISTNew Delhi: Union Minister of Health & Family Welfare Dr. Mansukh Mandaviya has virtually inaugurated the new building of CDSCO Bhawan, South...
Synokem Pharama gets CDSCO panel nod to manufacture, market Naftifine HCL Cream 2% Dr. Divya Colin22 Dec 2022 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Conduct CT in Indian population: CDSCO Panel Tells AstraZeneca for Anifrolumab Dr. Divya Colin19 Dec 2022 6:00 PM ISTNew Delhi: Highlighting that the there is no study data available in Indian population for monoclonal antibody Anifrolumab 150mg/ml concentrate for...
Novo Nordisk gets CDSCO Panel nod to study NN0365-3769 Dr. Divya Colin18 Dec 2022 5:00 PM ISTNew Delhi: In a significant development, the drug major Novo-Nordisk has got approval from the Subject Expert Committee (SEC) functional under the...
Novartis gets CDSCO panel nod to study anticancer drug JDQ443 Dr. Divya Colin17 Dec 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Novartis, has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
DCGI calls out WHO for 'prematurely' blaming Maiden Pharma for cough syrup linked deaths in Gambia Farhat Nasim16 Dec 2022 6:04 PM IST"It is clear that perhaps premature deduction was drawn on September 29th itself regarding the cause of death. Every subsequent alert or publication...
Submit Phase IV CT protocol: CDSCO Panel tells Roche over Anti-Cancer drug Pralsetinib Dr. Divya Colin16 Dec 2022 6:00 PM ISTNew Delhi: Reiterating the earlier recommendation regarding the condition of conduct a Phase IV clinical trial of anti-neoplastic drug Pralsetinib,...
CDSCO panel opines Johnson and Johnson to submit details of anticancer drug Teclistamab nod in EU, US Roshni Dhar16 Dec 2022 5:20 PM ISTIn response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the...
